Man Group
FLGT icon

Man Group’s Fulgent Genetics FLGT Stock Holding History

Man Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,759
Closed -$886K – 2049
2024
Q3 		$886K Buy
+40,759
New +$911K ﹤0.01% 1532
2023
Q1 		– Sell
-13,625
Closed -$438K – 1490
2022
Q4 		$406K Sell
13,625
-1,177
-8% -$42.1K ﹤0.01% 1569
2022
Q3 		$564K Buy
+14,802
New +$742K ﹤0.01% 1481
2022
Q2 		– Sell
-113,650
Closed -$6.25M – 1468
2022
Q1 		$7.09M Buy
113,650
+8,076
+8% +$532K 0.02% 750
2021
Q4 		$10.6M Buy
105,574
+13,200
+14% +$1.16M 0.03% 568
2021
Q3 		$8.31M Buy
92,374
+37,707
+69% +$3.43M 0.03% 646
2021
Q2 		$5.04M Buy
54,667
+950
+2% +$75.9K 0.02% 885
2021
Q1 		$5.19M Buy
+53,717
New +$5.55M 0.02% 673

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Man Group's FLGT Position: Q4 2024 in Review

Man Group sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 40,759 shares — an estimated $886K sold.

Man Group first reported a position in FLGT in Q1 2021 and held it in 8 quarters. The position peaked at $10.6M in Q4 2021. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Man Group reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Man Group sold 40,759 Fulgent Genetics shares in Q4 2024, an estimated $886K.
  • Man Group first reported a position in Fulgent Genetics in Q1 2021 and held it in 8 quarters.
  • Man Group's Fulgent Genetics position peaked at $10.6M in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Man Group's 13F filing for Q4 2024, filed 14 Feb 2025.